Rationale and design of the RIACT–study: a multi-center placebo controlled double blind study to test the efficacy of RItuximab in Acute Cellular tubulointerstitial rejection with B-cell infiltrates in renal Transplant patients: study protocol for a randomized controlled trial

Authors: Schiffer Lena, Schiffer Mario, Merkel Saskia, Schwarz Anke, Mengel Michael, Jürgens Christopher, Schroeder Christoph, Zoerner Alexander A, Püllmann Kerstin, Bröcker Verena, Becker Jan U, Dämmrich Maximilian E, Träder Jana, Großhennig Anika, Biertz Frank, Haller Hermann, Koch Armin, Gwinner Wilfried

Source: Trials, Vol 13, Iss 1, p 199 (2012)

Subject Terms: Cellular kidney allograft rejection, B-cells, Rituximab, Medicine (General), R5-920

File Description: electronic resource

Relation: http://www.trialsjournal.com/content/13/1/199; https://doaj.org/toc/1745-6215

Access URL: https://doaj.org/article/72c9e9076b9f47bea3310d40bb0438e7

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.